CD150-mediated Akt signalling pathway in normal and malignant B cells by Yurchenko, M. et al.
Experimental Oncology ��� ����� ���� ��arc�� �
CD150-MEDIATED AKT SIGNALLING PATHWAY IN NORMAL 
AND MALIGNANT B CELLS
M. Yurchenko1,*, L.M. Shlapatska1, O.L. Romanets 1, D. Ganshevskiy 1, E. Kashuba1,2,  
A. Zamoshnikova1, Yu.V. Ushenin3, B.A. Snopok3, S.P. Sidorenko1
1R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology NAS of Ukraine,  
Kyiv 03022, Ukraine
2Microbiology and Tumorbiology Center, Karolinska Institutet, Stockholm 171 77, Sweden
3V.E. Lashkarev Institute of Semiconductors Physics NAS of Ukraine, Kyiv 03028, Ukraine
Aim: To study upstream and downstream events in CD150-mediated Akt signaling pathway in normal human B cells, EBV-
transformed lymphoblastoid (LCL) and malignant Hodgkin’s lymphoma (HL) B cell lines. Methods: To access protein-protein 
interaction we applied immunoprecipitation, Western blot analysis and surface plasmon resonance (SPR) technique. A novel 
modification of SPR technique using reduced glutathione bound to golden surface was proposed. Immunostaining and isolation 
of cytoplasmic fractions and nuclear extracts were performed to detect proteins’ localization in cells. Western blot analysis was 
performed to follow up the phosphorylation of proteins on specific sites and proteins’ expression level. Results: It was shown that 
CD150 ligation induced Akt activation in normal tonsillar B cells (TBC), SH2D1A positive LCL and HL B cell lines. The p85α 
subunit of PI3K co-precipitated with CD150 cytoplasmic tail. This direct association depends on tyrosine phosphorylation and 
is mediated by N terminal SH2 domain of p85α. CD150 initiated phosphorylation of FoxO1 transcription factor in normal B cells 
as well as in LCL MP-1 and HL cell line L1236. At the same time, CD150 ligation triggered GSK-3β kinase phosphorylation 
only in immortalized LCL MP-1 and HL cell line L1236. Conclusions: We have demonstrated that CD150 receptor could trigger 
PI3K-mediated Akt signaling pathway in normal, EBV-transformed and malignant B cells. CD150-mediated phosphorylation of Akt 
downstream targets GSK-3β and FoxO1 in EBV-transformed and HL cells could be one of the mechanisms to avoid apoptosis and 
support survival program in these immortalized B cells. 
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CD�5� �IPO-�/SLA�� is a member of CD� family 
of t�e immonoglobulin �Ig� superfamily of surface 
receptors [��5]. It is expressed on activated T and 
B lymp�ocytes� dendritic cells and monocytes [�� 
6]. Low level of CD�5� expression was also found 
on natural killer T cells� platelets� basop�iles and ma-
ture dendritic cells [7� �]. T�is receptor is upregulated 
via antigen receptors� CD4�� Toll-like receptors and 
by mitogenes or cytokines �reviewed in [�]�. T�ere 
are experimental evidences t�at CD�5� and SH�D�A 
adaptor protein are co-expressed during a narrow 
window of B cell maturation� and SH�D�A may be in-
volved in regulation of B cell differentiation via switc�-
ing of CD�5�-mediated signaling pat�ways [��� ��]. 
CD�5� is co-expressed wit� SH�D�A adaptor protein 
in some B-lymp�oblastoid cell lines and lymp�oma 
cells wit� activated B cell p�enotype� suc� as Hodg-
kin’s lymp�oma �HL� and ABC-type diffuse large B cell 
lymp�oma [��� ��].
Tumor cells of classical HL are known as Hodgkin 
and Reed-Sternberg cells �HRS�� and originate from 
preapoptotic germinal center B cells t�at do not ex-
press functional B cell receptor �BCR� [��� �4]. HRS 
cells are able to escape t�e regulation mec�anisms 
aimed to eliminate B cells lacking functional BCR. Sev-
eral aberrantly activated signaling pat�ways �ave 
been identified t�at contribute to t�e rescue of HRS 
cells from apoptosis: JAK-STAT [�5� �6]� �APK/ERK 
initiated by CD��-� CD4�-� RANK [�7] and CD�5� [��] 
signaling� PI�K/AKT linked to CD4� [��]� L�P� and 
L�P�a in EBV-positive cases [�����]; NF-kappaB due 
to aberrant expression� mutations� CD4�� CD�� stimu-
lation �reviewed in [��� �4� ��]�.
Activation of t�e p�osp�atidylinositol �-kinase 
�PI�K� pat�way �as been linked wit� tumor cell growt�� 
survival and resistance to t�erapy in several cancer 
types [�4]. T�e main downstream PI�K effector� w�ic� 
controls t�e survival of normal and malignant cells� 
is Akt/PKB [�5]. Ligation of tumor necrosis factor �TNF� 
family receptors could induce Akt p�osp�orylation/ac-
tivation in normal [�6] and HRS cells [��]. Previously� 
we �ave demonstrated t�at Akt could be activated via 
CD�5� in DT4� model system� lymp�oblastoid cell line 
�P-� [��� �7] and HL cells L���6 [��]. T�e �ypot�esis 
was proposed t�at CD�5�-SH�D�A association could 
play decisive role in CD�5�-mediated Akt signaling. 
In current study we furt�er explored t�e upstream and 
downstream events in CD�5�-mediated Akt pat�way 
in normal and malignant B cells.
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MATERIALS AND METHODS
Cell lines. T�e B lymp�oblastoid cell lines �B-LCL� 
�P-�� CESS� T5-�� fres�ly infected LCLs from pe-
rip�eral blood B cells and HL cell line of B cell origin 
L���6 were maintained in RP�I �64� medium con-
taining ��% FBS� � m� L-glutamine� and antibiotics.
Human tissue specimens. After receiving 
informed consent in accordance wit� t�e Declara-
tion of Helsinki� fres� tonsils were obtained from 
�� patients undergoing tonsillectomy. Tonsillar B cells 
were isolated by density fractionation on discontinu-
ous Lymp�oprep �Axis-S�ield PoC AS� Norway� and 
Percoll �Sigma� USA� gradients as described [��]. 
�6.5���.6% of cells in CD�- populations were of B cell 
lineage since expressed CD�� and/or CD��� antigens.
GST proteins preparation. GST-fusion con-
structs of CD�5� cytoplasmic tail �CD�5�ct� were 
prepared earlier and described in [��� �7]. cDNA 
of p�5α regulatory subunit was a kind gift of Dr. I. Gout 
�University College� London� UK�. N-terminal SH� do-
main of p�5α regulatory subunit was cloned into pGEX-
�T vector using specific primers� and sequenced 
�we t�ank for t�e �elp Dr. Vladimir Kas�uba� �TC� 
Karolinska institutet� Sweden�. T�e plasmid encoding 
GST-SH�D�A was kindly provided by Dr. Kim Nic�ols 
�T�e C�ildren’s Hospital of P�iladelp�ia� P�iladelp�ia� 
PA� USA�. Plasmids containing GST-CD�5�ct� GST-
SH�D�A and GST-NSH�-p�5α were transformed into 
t�e Escherichia coli strains BL��DE� �Invitrogen� USA� 
to produce non-p�osp�orylated fusion proteins� and 
GST-CD�5�ct wit� and wit�out point mutations were 
transformed to TKX� strain �Stratagene� USA� for pro-
duction of tyrosine-p�osp�orylated fusion proteins.
Surface plasmon resonance (SPR) instrumen-
tation and SPR analysis. T�e substrates and cell 
design of scanning SPR spectrometer “BioSuplar” 
�“PLAS�ON-��5”� �V. Las�karev Institute of Semicon-
ductor P�ysics� NAS of Ukraine� Kyiv� Ukraine� as well 
as its ot�er c�aracteristics are described in [��]. T�is 
spectrometer� w�ic� �as open measurement arc�itec-
ture� was used to study protein�protein interactions. 
T�e peristaltic pump provided a constant solution flow 
�> 5� μl/min� t�roug� t�e experimental cell. SPR kinet-
ics was analyzed wit� a model t�at takes into account 
t�e �eterogeneous processes at t�e interface using 
a stretc�ed exponential function [��]. 
Surface modification and protein immobiliza-
tion. T�e surface cleaning and activation procedure �for 
planar metal electrodes of SPR c�ips� eac� wit� a metal 
layer 5�� Å t�ick consisting of a 45�-Å layer of gold 
on a 5�-Å c�romium ad�esive layer� was carried out 
at room temperature as follows. To remove organic con-
tamination� t�e c�ips were was�ed in a fres�ly prepared 
mixture of aqueous �NH4��S�O� ��.�� �� and H�O� ���%� 
��5:6 vol:vol� for �� min. Traces of �eavy metal ions were 
removed wit� a fres�ly prepared mixture H�O� ���%� 
and HCl ��7%� in water ��:�:�� vol:vol:vol� for �� min. 
T�e surface was modified by t�iols СOOH-�CH����-SH 
��.� μМ� and CH�-�CH���-SH �� μМ�� �Sigma� USA� 
in ratio �:��� ��� �� �7 °С� [��]. C�ips were was�ed 
by et�anol. Cadmium acetate ��� m� solution� room 
temperature� was used for activation of carboxyl groups 
at least for � � prior experiment. Cadmium acetate was 
used as an immobilization bridge� w�ic� �as selectiv-
ity to t�iogroup of glutat�ione �as ligand� and interacts 
wit� carboxyl groups on c�arged t�iols. Glutat�ione 
immobilization: � m� solution of reduced glutat�i-
one �Sigma� USA� in TBE buffer �рН �.�� was applied 
on c�ips’ surface for � � at room temperature. Proteins 
were immobilized in PBS buffer.
Biochemical methods and antibodies. Cell ly-
sis� SDS-PAGE� Western blotting� stimulation of cells 
by anti-CD4� �G��-5� kind gift of Prof. Edward Clark� 
University of Was�ington� Seattle� WA� USA�� anti-Ig� 
�AffiniPure F�ab’�� fragment goat anti-�uman Ig� 
Fc5μ fragment specific� Jackson ImmunoResearc� 
laboratories� West Grove� PA� USA�� anti-CD�5� mAb 
�IPO-�� produced in IEPOR NASU� Kiev� Ukraine�� 
CD�5� immunoprecipitations were performed as de-
scribed earlier [��� �7]. Western blot results were 
visualized using a ��x LumiGLO® Reagent and ��x Per-
oxide �Cell Signaling Tec�nology� Beverly� �A� USA�. 
Goat antisera against actin� was purc�ased from Santa 
Cruz Biotec�nology �Santa Cruz� CA� USA�. Rabbit 
anti-SH�D�A serum was a kind gift of Dr. Kim Nic�ols 
�T�e C�ildren’s Hospital of P�iladelp�ia� P�iladelp�ia� 
PA� USA�. Rabbit anti-pAkt �Ser47�� and �T�r����� 
anti-Akt� anti-pFoxO��T�r�4�/Fox��a�T�r���� anti-
FoxO�� anti-FoxO�a� anti-pGSK-�β �Ser��� anti-PI�K 
p�5α antibody� anti-PARP� anti-Bcl-� were purc�ased 
from Cell Signaling Tec�nology �Beverly� �A� USA�.
Immunostaining.  T�e double staining for 
CD�5� receptor and SH�D�A adaptor protein was 
done as follows: cells were spun on glass slides 
��� x ��4 per slide�; fixed in cold met�anol-acetone 
��:�� at ��� oC for � �; re�ydrated wit� PBS for � �; 
stained wit� anti-CD�5� �IPO-�� mAb �5 μg/ml� for 
� �� followed by � was�es in PBS; incubated wit� 
�orse anti-mouse Texas Red-conjugated antibodies 
�VectorLab� CA� USA�� and was�ed � times. Cells were 
stained wit� anti-SH�D�A antibodies �dilution �:���� 
for � �� t�ree was�es in PBS� incubated wit� mouse 
anti-rabbit FITC-conjugated antibodies �DAKO� Den-
mark�� and mounted wit� ��% glycerol solution in PBS 
t�at contained �.5% ��4-diazabicyclo-��.�.��octane 
�Sigma�. Bisbenzimide �Hoec�st ���5�� was added 
at a concentration of �.4 μg/ml to t�e last secondary 
antibody for DNA staining. T�e images were recorded 
on a DAS microscope Leitz D� RB �Leica Inc.� Deer-
field� IL� USA� wit� a Hamamatsu dual mode cooled 
CCD camera C4��� �Hamamatsu City� Japan�.
Isolation of cytoplasmic fraction and nuclear 
extracts. Total cell lysates �TCL� were prepared from 
5 x ��6 of cells in RIPA lysis buffer ��5� m� NaCl� 
�� m� Tris-HCl �pH �.��� � m� EGTA� � m� EDTA 
�pH �.��� �% Tryton X-���� protease in�ibitors’ cocktail 
�Sigma� USA�� � m� P�SF�� and sonicated on ice for 
�5 s �Sonicator �SE Soniprep �5� Plus� �SE �UK� 
Limited� UK�� spun for �5 min� �7��� g� +4 oC� su-
pernatants transferred to fres� tubes. For subcellular 
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fractionation� control and stimulated cells ��� x ��6� 
were lysed in buffer A �5� m� NaCl� �� m� HEPES 
�pH �.��� 5�� m� sucrose� � m� EDTA �pH �.��� 
�.�% Tryton X-���� protease in�ibitors’ cocktail 
�Sigma� USA�� � m� P�SF�� vortexed and spun for 
� min ��75 g� +4 oC�. Cytoplasmic fractions �Cyt� 
of supernatant were collected to fres� tubes. Pellets 
�nuclei� were was�ed twice by �.5 ml of cold buffer B 
�5� m� NaCl� �� m� HEPES �pH �.��� �5% glycerol� 
�.� m� EDTA �pH �.��� and spun for � min ��75 g� 
+4 oC�. Pellets were resuspended in ��� μl of buffer C 
��5� m� NaCl� �� m� HEPES �pH �.��� �5 % glycerol� 
�.� m� EDTA �pH �.��� protease in�ibitors’ cocktail 
�Sigma� USA�� � m� P�SF�� and sonicated on ice for 
�5 s� spun for �5 min� �7��� g� +4 oC�  and superna-
tants were transferred to fres� tubes. TCL� NE and Cyt 
fractions were stored at -�� oC. Protein concentration 
was measured in all samples �TCL� NE� Cyt�� and total 
amount of �� μg of protein was loaded to eac� well for 
Western blot analysis.
RESULTS
p85α subunit of PI3K co-precipitates with 
CD150 cytoplasmic tail. Previously� we �ave s�own 
t�at CD�5�-mediated signals lead to Akt S47� p�os-
p�orylation in �uman B-lymp�oblastoid cell line 
�P-� [�7] and c�icken B cell line DT4� [��]. �oreover� 
using DT4� model system it was s�own t�at CD�5�-
mediated Akt pat�way was dependent on SH�D�A 
binding to CD�5�� was negatively regulated by Lyn and 
Btk� and positively - by Syk [��]. Also� anot�er member 
of CD� family� CD�44 ��B4�� upon tyrosine p�osp�ory-
lation was s�own to recruit not only SH�D�A� but also 
associate wit� t�e p�5α regulatory subunit of PI�K 
[��].  To answer t�e question w�et�er CD�5� could 
form a complex wit� PI�K in B cells� we performed 
immunoprecipitations of CD�5� by specific mAb 
�IPO-�� from tonsillar B cell �TBC� and �P-� lysates. 
Western blot analysis of t�ese immunoprecipitates 
demonstrated t�at p�5α regulatory subunit of PI�K 
co-precipitated wit� CD�5� from bot� examined 
lysates �Fig. ��.
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Fig. 1. PI�K p�5α regulatory subunit precipitated wit� CD�5� re-
ceptor bot� from �P-� and tonsillar B cells �TBC�. Western blot 
analysis wit� anti-p�5α of CD�5� immunoprecipitates. Ig isotype 
matc�ed �OPC�� antibody served as negative control 
CD150ct directly interacts with p85α subunit 
N terminal SH2 domain of PI3K. To test w�et�er 
p�5α regulatory subunit of PI�K directly binds 
CD�5� cytoplasmic tail we applied surface plasmon 
resonance �SPR� approac�. For SPR-based analy-
sis of protein-protein interactions we used tyrosine 
p�osp�orylated and non-p�osp�orylated GST-fused 
cytoplasmic tail of CD�5� �GST-CD�5�ct� wit� point 
mutations �Y/F substitution� in ITS� motifs� described 
earlier [��]. Also� fusion proteins of GST-SH�D�A� 
GST-fused N-terminal SH� domain of p�5α regula-
tory subunit of PI�K �GST-NSH�-p�5alp�a� were used 
in t�is study. GST-NSH�-p�5alp�a was c�osen since 
it was demonstrated for p�5-associated receptors EGF 
and PDGF t�at t�e affinity of t�e N-SH� domain of p�5α 
for t�e receptors correlated wit� t�e steady-state level 
of p�5-receptor complex [�4]. T�e quantitative ratio 
of protein partners was calculated based on molecular 
weig�t of interacting proteins.
Interaction between GST-fusion proteins 
of CD�5�ct �GST-CD�5�ct� and SH�D�A �GST-
SH�D�A� was s�own to be �:� for non-p�osp�oryl-
ated GST-CD�5�ct �Fig. �� a�� and �:� for tyrosine 
p�osp�orylated GST-CD�5�ctPY and GST-SH�D�A 
�Fig. �� b�. T�is ratio corresponds to t�e data obtained 
by bioc�emical studies� s�owing t�at immunotyrosine 
based switc� motif �ITS�� wit� non-p�osp�orylated 
tyrosine Y��� could bind SH�D�A� and t�at bot� 
ITS�s wit� Y��� and Y��7 could bind adaptor protein 
SH�D�A w�en p�osp�orylated [��� �5]. T�us� our 
results obtained by SPR approac� wit� glutat�ione 
immobilized on golden c�ips� completely matc� wit� 
previously obtained results for CD�5�-SH�D�A inter-
action� and� t�erefore� t�is approac� could be used for 
studies of GST-CD�5�ct direct interaction wit� ot�er 
SH�-domain containing proteins.
Using t�is approac� we examined GST-NSH�-
p�5alp�a interaction wit� non-p�osp�orylated 
�Fig. �� c� and tyrosine p�osp�porylated GST-CD�5�ct 
�Fig. �� d�. It was found t�at NSH� domain of p�5α sub-
unit interacts only wit� tyrosine p�osp�orylated recep-
tor �see Fig. �� d�. To determine� w�ic� tyrosines �Y���� 
Y��7� in CD�5�ct are essential for CD�5� - NSH� p�5α 
interaction we used fusion proteins of CD�5�ct wit� 
point mutations Y/F. It was s�own t�at mutation Y��7F 
did not alter CD�5�ct-p�5α SH� interaction. However� 
double mutant Y���F/Y��7 did not bind p�5α SH� do-
main �data not s�own�. T�us� t�e first ITS� motif con-
taining Y��� s�ould be available and p�osp�orylated 
for NSH�-p�5α interaction wit� CD�5�ct.
T�us� we demonstrated by SPR t�at p�5α subunit 
of PI�K via its N terminal SH� domain could directly 
bind CD�5�ct� and t�at t�is interaction takes place 
in normal TBC and lymp�oblastoid cell line �P-�. T�e 
direct interaction of CD�5� wit� p�5α subunit of PI�K 
could be a starting point for regulation of PI�K activa-
tion and subsequent Akt activation via CD�5�.
CD150-mediated Akt activation in lympho-
blastoid cell lines. �P-� and CESS lymp�oblastoid 
cell lines bot� express CD�5� and SH�D�A proteins. 
Here we demonstrate t�at CD�5� ligation led to p�os-
p�orylation of bot� Akt activation sites �T��� and S47�� 
in �P-� cells �Fig. ��. In CESS cells CD�5� ligation 
induce only slig�t Akt p�osp�orylation on T��� and 
S47�� and CD�5� signals �ad no effect on Akt p�os-
p�orylation levels in T5-� cells and fres�ly obtained 
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from p�erip�eral blood B cells LCLs �see Fig. ��. T�ese 
cell lines differed by adaptor protein SH�D�A expres-
sion levels: �P-� cells expressed SH�D�A protein 
at �ig� level� CESS cells and LCLs � at muc� lower 
level� and T5-� cells did not express SH�D�A at all 
�[��] and data not s�own�.
CD150 and SH2D1A localization in lympho-
blastoid cell lines. Studies performed on regulation 
of CD�5�-mediated Akt activation in DT4� model sys-
tem [��] and Hodgkin’s lymp�oma cell lines [��� ��] 
�ave s�own t�at CD�5�-mediated Akt activation could 
be regulated by SH�D�A expression and its cellular 
localization. Using immunofluorescent staining �ere 
we found t�at in �P-� and CESS cells SH�D�A was 
localized in cytoplasm close to t�e cellular membrane 
�Fig. 4�. Practically all �P-� cells in contrary to ��% 
of CESS cells were SH�D�A positive �see Fig. 4�. 
As CD�5�-SH�D�A interaction was s�own to be crucial 
for Fyn recruitment and CD�5� tyrosine p�osp�oryla-
tion at least in T cells [�6� �7] we examined t�e p�os-
p�orylation of receptor in bot� cell lines. It was s�own 
t�at CD�5� �ad lower level of tyrosine p�osp�orylation 
in CESS cells t�an in �P-� cells �data not s�own�. 
T�us� t�e level of SH�D�A expression directly corre-
lated wit� tyrosine p�osp�orylation. Since p�5α PI�K 
binds only to tyrosine p�osp�orylated CD�5�� obtained 
data could explain t�e lack of CD�5�-mediated Akt 
p�osp�orylation in cells� w�ic� do not express SH�D�A 
or �ave low expression level of t�is adaptor protein.
Akt activation in primary B cells. CD�5�-
mediated Akt p�osp�orylation was studied in dense 
�naive and memory B cells� and buoyant fractions 
�activated cells� of TBC. It was s�own t�at Akt kinase 
could be p�osp�orylated via CD�5� bot� in naïve and 
activated primary TBC �Fig. 5a, b�. As a control� cells 
were stimulated via B cell receptor. It was found t�at 
stimulation of dense TBC via CD�5� and Ig� �ad ad-
ditive effect on Akt p�osp�orylation �Fig. 5a, c, grap��.
Akt distribution between cytoplasmic and 
nuclear fractions in LCL and HL cell lines. Subcel-
lular localization of Akt kinase is very important for its 
function. In resting unstimulated cells Akt molecules 
resides bot� in t�e cytoplasm and nucleus [��]. Activa-
tion of Akt occurs in proximity of plasma membrane and 
�as been s�own to be followed by pAkt translocation 
to cytosol and nucleus [��]. Suc� translocation allows 
pAkt to p�osp�orylate its downstream targets� among 
w�ic� t�ere are cytoplasmic as well as nuclear proteins. 
In current study we addressed t�e question �ow 
Akt kinase was distributed between nucleus and cy-
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Fig. 2. Representative SPR responses of protein-protein interactions �a-d�. Non-tyrosine p�osp�orylated GST-CD�5�ct interacted wit� 
GST-SH�D�A protein in ratio �:� �a�. Tyrosine p�osp�orylated GST-CD�5�ct �GST-CD�5�ctPY� interacted wit� GST-SH�D�A protein 
in ratio �:� �b�. Non-tyrosine p�osp�orylated GST-CD�5�ct did not bind to GST-NSH�-p�5alp�a �c�. GST-CD�5�ctPY interacted wit� 
GST-NSH�-p�5alp�a in ratio �:� �d�
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toplasm in EBV-transformed cells �P-� and HL cells 
�L���6� before and after stimulation via surface 
receptors CD4� and CD�5�. Before ligation of recep-
tors� Akt kinase was mainly localized in cytoplasmic 
fraction in L���6 HL cells� and partially in t�e nuclear 
extract �Fig. 6� a�. Upon stimulation of L���6 cells via 
CD�5� and CD4� receptors� Akt was completely ex-
ported from t�e nucleus. In �P-� cells� Akt kinase was 
localized exceptionally in cytoplasm �Fig. 6� b�. Signals 
via CD4� or CD�5� receptor �ad no influence on Akt 
distribution between nucleus and cytoplasm �Fig. 6� b�. 
CD150-mediated phosphorylation of Akt down-
stream targets in normal and malignant B cells. Akt 
kinase regulates t�e activity of multiple target proteins 
in cells� w�ic� results in promotion of cell survival 
and in�ibition of apoptosis. Among t�em are stress-
activated kinases� BAD� Fork�ead family of transcrip-
tion factors� IκB kinase� GSK-�� mTOR� c-Raf� B-Raf� 
Nur77� etc �reviewed in [�4]�.
GSK-� serine/t�reonine protein kinase is one 
of t�e crucial Akt target proteins. Two �omologous 
mammalian GSK-� isoforms� encoded by different 
genes� are known � GSK-�α and GSK-�β. Akt could 
p�osp�orylate GSK-�α on S�� and GSK-�β on S�� and 
inactivate t�ese proteins [��]. We examined if CD�5�-
mediated Akt activation could lead to p�osp�orylation 
of GSK-�β in primary TBC� LCL �P-� and HL cell line 
L���6. It was found t�at in primary TBC� bot� in dense 
and buoyant fractions� t�e basal level of GSK-�β 
p�osp�orylation on S� was very �ig�� and it was not 
altered by stimulation via CD�5� receptor �Fig. 7� a�. 
At t�e same time� CD�5�-mediated Akt activation 
bot� in �P-� and L���6 cells resulted in upregulation 
of GSK-�β S� p�osp�orylation wit� kinetics similar 
to Akt S47� p�osp�orylation �Fig. 7� b, c�.  
FoxOs transcription factors constitute important 
downstream targets of t�e PI�K/Akt signaling pat�-
way. FoxOs are regarded as tumor suppressor genes 
�reviewed in [4�]�. FoxOs regulate transcription of pro-
apoptotic genes� w�ile Akt kinase protects cells from 
apoptosis by p�osp�orylating FoxOs� w�ic� target 
t�em to �4-�-�-mediated nuclear export and/or pro-
teosome-mediated degradation [4��4�]. T�e sites for 
Akt p�osp�orylation in FoxO� are T�4� S�56 and S���� 
and for FoxO�a are T��� S�5� and S��5 �reviewed in 
[4�]�. Here we explored CD�5�-mediated p�osp�ory-
lation of FoxO�/FoxO�a on T�4/T�� in comparison 
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Fig. 3. CD�5�-mediated Akt p�osp�orylation on serine 
47� �S47�� and t�reonine ��� �T���� in lymp�oblastoid cell 
lines �a�. Akt kinase was markedly p�osp�orylated on bot� 
sites S47� and T��� in �P-� cells� only slig�tly p�osp�orylated 
in CESS cells �a, upper panels�. T�e level of Akt p�osp�orylation 
was not altered in T5-� and LCL �b� lower panels�. Equal loading 
was monitored by anti-actin or anti-Akt Western blot
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Fig. 4. Double immunostaining of CD�5� and SH�D�A demonstrated t�at t�ese two proteins are co-expressed and co-localized close to t�e 
cellular membrane in all �P-� cells. Only ��% of CESS cells were SH�D�A positive� and SH�D�A was also co-localized wit� CD�5�� x4��
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to stimulation via CD4� and Ig� receptors. We found 
t�at only FoxO�� but not FoxO�a is expressed in TBC� 
�P-� and HL cells L���6 on protein level �data not 
s�own�. It was s�own t�at FoxO� p�osp�orylation 
level on T�4 was upregulated via CD�5� and Ig�� but 
not CD4� in dense fraction �naïve and memory cells� 
of TBC �Fig. �� a� upper panel�. In buoyant TBC t�e level 
of pFoxO� was not altered by eit�er CD�5� or CD4� li-
gation� but was only en�anced by ligation of Ig� �see 
Fig. �� a� lower panel�.
T�e basal p�osp�orylation level of FoxO� on T�4 was 
quite �ig� in LCL �P-�. Nevert�eless signals via CD�5� and 
CD4� upregulated t�e level of pFoxO� in �� and 6� min 
upon stimulation �Fig. �� b� grap��. T�e effect of CD�5� li-
gation was more pronounced t�an of CD4� �see Fig. �� 
b� grap��.
Similarly� in HL cells L���6 bot� signals via 
CD�5� or CD4� receptors significantly en�anced t�e 
p�osp�orylation of FoxO� T�4 in �5 and 6� min upon 
receptors’ ligation� �owever� effect of CD4� crosslink-
ing was more prominent �Fig. �� c�.
DISCUSSION
T�e serine/t�reonine kinase Akt/PKB is a crucial 
regulator of divergent cellular processes� including 
proliferation� differentiation and apoptosis [�4]. Akt 
signaling is often deregulated in cancer� leading 
to constitutively active Akt kinase [�4]. 
T�e p�osp�orylation of Akt �pAkt S47�� was found 
to be upregulated in HL derived cell lines and in HRS 
cells in 64% [��] and ���% [44] of primary lymp� node 
sections of HL. In all tested cases� Akt was detected 
bot� in HRS cells and t�e surrounding reactive cells� 
w�ile active p�osp�orylated form of Akt was expressed 
only by t�e HRS cells [��]. T�is �ig� level of basal Akt 
p�osp�orylation t�oug�t to be maintained by signals 
via tumor necrosis factor �TNF� family receptors CD4�� 
RANK� and CD�� [��]. We �ave s�own previously 
t�at CD�5� receptor mediated signaling could also 
contribute to Akt activation in HL cells [��� ��]. Here 
we demonstrated t�at t�is signaling pat�way could 
be activated via CD�5� in primary normal B cells� 
as well as in LCL and HL cell lines. 
Previously� it was s�own t�at CD�5�ct interac-
tion wit� adaptor protein SH�D�A was necessary for 
CD�5� interaction wit� protein kinases and ITS�s’ 
p�osp�orylation [�6� 45]. Our data suggested t�at 
CD�5�-SH�D�A association and SH�D�A localization 
play decisive role in activation of Akt signaling pat�way 
upon CD�5� ligation �Fig. �� 4�. 
Based on our data it could be suggested t�at 
SH�D�A adaptor protein association wit� CD�5�ct 
allows tyrosine p�osp�orylation of CD�5�ct by cellular 
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and �P-� �b� cells. Akt kinase was localized bot� in Cyt and 
NE of L���6 cells� and was completely exported from t�e nucleus 
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per panel�. In �P-� cells� Akt was localized only in cytoplasmic 
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tyrosine kinases �Lyn in B cells [��]�� w�ic� permit direct 
interaction of CD�5�ct and p�5α regulatory subunit 
of PI�K. Immunoprecipitation of CD�5� from �P-� cells 
and TBC demonstrated t�at CD�5� co-precipitated 
wit� p�5α �Fig. ��. By SPR approac�� we demonstrated 
t�at t�is interaction was direct� dependent on CD�5�ct 
p�osp�orylation �Fig. �� c,d�� and ITS� motif containing 
Y��� was necessary for NSH�-p�5α interaction wit� 
CD�5�ct. T�us� CD�5�-initiated Akt activation in B cells 
was mediated by direct interaction of CD�5�ct wit� p�5α 
regulatory subunit of PI�K.
For SPR analysis we applied modification of met�-
od first proposed by Boltovets et al. [��]� w�en glu-
tat�ione is fixed on t�e golden surface of sensor c�ips. 
T�is low-cost and effective modification of met�od 
for GST-protein immobilization on sensor c�ips could 
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Fig. 8. CD�5�-mediated p�osp�orylation of Akt target protein 
FoxO� transcription factor on T�4 in TBC� �P-� and L���6 cell 
lines. T�e basal level of pFoxO� was �ig� bot� in dense and 
buoyant TBC fractions �a� control�. Ligation of receptors medi-
ated t�e upregulation of pFoxO� level in dense cells� and �ad 
almost no influence on pFoxO� level in buoyant cells �a�. LCL 
�P-� was c�aracterized by �ig� basal level of FoxO� p�osp�ory-
lation� w�ic� was upregulated by CD�5�- and CD4�-mediated 
signaling �b�. CD�5� and CD4� induced strong upregulation 
of pFoxO� level in HL cell line L���6 �c�. T�e level of pFoxO� was 
normalized against actin or FoxO� levels using TotalLab program 
�grap�s�. Anti-pAkt Western blot was performed to monitor Akt 
p�osp�orylation upon ligation of CD�5� receptor. Equal loading 
was monitored by anti-actin or anti-FoxO� Western blot
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be efficiently applied to study ot�er protein-protein 
interactions using GST fusion proteins as interacting 
partners wit�out using specific antibodies.
Several downstream effectors of Akt signaling� in-
cluding GSK-�α/β� and mTOR substrates 4E-BP� and 
p7� S6 kinase� were s�own to be p�osp�orylated 
in primary HL cells [44]. GSK-� is one of t�e crucial Akt 
target protein. GSK-� p�osp�orylates a broad range 
of substrates and is implicated in multiple biological 
processes apart from its well studied function as regu-
lator of glycogen synt�esis. GSK-�β �as been s�own 
to regulate cyclin D� proteolysis and subcellular local-
ization during t�e cell division cycle� t�ereby triggering 
rapid cyclin D� turnover [46]. Also GSK-� controls 
transcription factor c-myc proteolysis and subnuclear 
localization as p�osp�orylation of c-�yc T5� facilitates 
its rapid proteolysis by t�e ubiquitin pat�way [47].
We �ave demonstrated t�at GSK-�β was p�os-
p�orylated upon CD�5� ligation in �P-� and HL cell 
line L���6� but not in normal TBC �Fig. 7�. It seems 
like regulation of GSK-�β p�osp�orylation level/
inactivation via CD�5� receptor is more critical for 
immortalized tumor cells �HL� and EBV-transformed 
cells �LCL�� w�ic� use all cellular signaling mac�inery 
to avoid apoptosis and support t�eir proliferation. 
In normal TBC GSK-�β is initially switc�ed off ��ig�ly 
p�osp�orylated on in�ibitory site�� w�ic� is probably 
needed for furt�er differentiation of t�ese cells.
In mammalian cells� t�e class O of fork �ead �fk�� 
transcription factors is �omologous to Caenorhab-
ditis elegans transcription factor DAF-�6 �abnormal 
DAuer Formation-�6�� and consists of four members: 
FoxO�� FoxO�� FoxO4 and FoxO6 [4�]. Several ki-
nases were s�own to p�osp�orylate FoxOs in different 
sites: Akt� serum and glucocorticoid-inducible kinase 
�SGK�� mammalian sterile ��-like kinase-� ��ST��� 
cyclin-dependent kinase-� �CDK��� p��-kDa ribo-
somal S6 kinase-� �Rsk-��� dual-specificity tyrosine-
p�osp�orylated and regulated kinase �A �DYRK�a� 
�reviewed in [4�� 4�� 4�]�. As to t�e ot�er post-trans-
lational modifications� FoxOs activity/stability could 
be regulated by acetylation and ubiquitination [5�]. 
In our study we s�owed t�at despite t�e �ig� basal 
level of pFoxO�� CD�5� mediated FoxO p�osp�oryla-
tion in normal TBC and LCL �P-� �Fig. ��. �oreover� 
CD�5� as well as CD4� was involved in inactivation 
of pro-apoptotic FoxO� transcription factor in HL cell 
line L���6� w�ic� could contribute to t�e survival 
of HRS cells. In s�ould be emp�asized t�at all studied 
B cells expressed FoxO�� but not FoxO�a on protein 
level. It is an important finding since it was t�oug�t 
t�at t�e dominant isoform expressed in lymp�ocytes� 
at least on mRNA level� is FoxO�a [4�].
Recently� we �ave s�own t�at CD�5� mediates JNK 
activation in normal and HL cells [��]. JNK kinases 
could p�osp�orylate FoxO in transactivating domain 
[5�]. Also� JNK �as been s�own to p�osp�orylate �4-
�-� proteins� w�ic� result in reduced �4-�-� binding 
to partner proteins� including FoxOs [5�]. Regulation 
of multiple posttranslational modifications of FoxOs via 
CD�5�-mediated JNK and ot�er signaling pat�ways 
s�ould be furt�er explored to get more clear under-
standing of t�e FoxOs activity regulation in normal and 
malignant B cells.
Subcellular localization of Akt kinase is important 
for downstream cytoplasmic and nuclear protein 
targets p�osp�orylation. Using model cell lines it was 
s�own t�at activation of Akt results in its nuclear 
translocation wit�in �� to �� min after stimulation [5�]. 
Following BCR stimulation of mouse B cell line pAkt 
resides bot� in t�e cytosol and nucleus [��]. In HL cell 
lines K�-H� and L4�� pAkt was localized close to t�e 
membrane or in cytosol [44]. Here we �ave s�own 
t�at in unstimulated L���6 cells Akt kinase was pres-
ent bot� in cytoplasmic fraction and nuclear extract. 
Upon stimulation of cells via CD�5� and CD4�� Akt 
was completely exported from t�e nucleus �Fig. 6�. 
It is consistent wit� t�e fact t�at in most studied cases 
of primary HL in HRS cells pAkt was s�own to be pref-
erentially cytoplasmic [44]. T�is could be ac�ieved 
by sustained signals via TNF receptors �including 
CD4�� and CD�5�. However� t�e biological effect 
of t�is nuclear-cytoplasmic translocation in HL cells 
s�ould be studied furt�er. We �ave s�own previously 
t�at sustained signaling via CD�5� and CD4� recep-
tors induced in�ibition of cellular proliferation and cell 
deat� of L���6 cells [��]. We may �ypot�esize t�at 
retaining of Akt in cytoplasm would prevent t�e p�os-
p�orylation of its nuclear targets in t�ese cells� w�ic� 
could be t�e reason of inability of Akt survival pat�way 
to in�ibit CD�5�-induced cell deat�. 
Alt�oug� t�e PI�K/Akt pat�way in�ibits apoptosis 
and promotes cell cycle progression and proliferation 
[�4]� t�e consequences of its activation in HRS cells 
remain currently unclear. T�oug� Dutton et al. [44] 
s�owed t�at HL cell lines and primary HL tumor cases 
were c�aracterized by �ig� levels of p�osp�orylated/
activated Akt� in�ibition of PI�K and mTOR �ad quite 
modest effect on cell survival. At t�e same time� 
ot�er aut�ors [��] demonstrated t�at PI�K in�ibitor 
LY��4��� �ad anti-proliferative and pro-apoptotic ef-
fects on some studied HL cell lines. �oreover� CD�5�-
stimulation of L���6 HL cell line induced cell deat�� 
t�oug� t�is cell line was c�aracterized by simultaneous 
fast and marked Akt activation via CD�5� receptor [��]. 
T�us� outcome of PI�K/Akt signaling cascade may 
depend on interaction wit� ot�er signaling pat�ways 
t�at are initiated by different stimuli from HL microen-
vironment.
Taken toget�er� in current study we �ave s�own t�at 
CD�5� ligation induced Akt p�osp�orylation/activation 
in normal TBC� LCLs and HL cell lines. It could be as-
sumed t�at CD�5�-mediated activation of Akt kinase 
depends on CD�5�-SH�D�A interaction followed 
by p�osp�orylation of CD�5�ct and attraction of p�5α 
regulatory subunit of PI�K. Akt kinase� activated via 
CD�5�� could p�osp�orylate its downstream target 
FoxO� transcription factor in normal B cells� as well 
as in immortalized HL and B-lymp�oblastoid cell lines. 
At t�e same time Akt p�osp�orylation of its substrate 
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GSK-�β kinase was detected only in HL cell line 
L���6 and LCL �P-�� but not in normal TBC. CD�5�-
mediated Akt signaling� followed by regulation of GSK-
�β and FoxO� activity in EBV-transformed and HL tu-
mor cells could interplay wit� ot�er CD�5�-initiated 
signaling pat�ways �i.e. �APK� creating signaling 
network favorable for maintaining t�e survival program 
and escaping apoptosis of transformed B cells. 
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